Laurus labs-
Richcore
Aim to be a integrated player by Backward integration
New site for formulations
Increase in formulation capacity
Non ARV API significant jump expected by 2023 .
Dr Chava is very bullish on hormone and steriods segment
Laurus Labs- LMIC and Europe and North America Revenue Split
CRAMS capacity
( Laurus My old Notes- Read it to understand its business in simple language ( Presplit around 500 Rs)
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.